118 related articles for article (PubMed ID: 19006771)
1. Diagnosis of ductal carcinoma in situ using contrast-enhanced magnetic resonance mammography compared with conventional mammography.
Vag T; Baltzer PA; Renz DM; Pfleiderer SO; Gajda M; Camara O; Kaiser WA
Clin Imaging; 2008; 32(6):438-42. PubMed ID: 19006771
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
3. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing.
Dietzel M; Baltzer PA; Vag T; Gröschel T; Gajda M; Camara O; Kaiser WA
J Comput Assist Tomogr; 2010 Jul; 34(4):587-95. PubMed ID: 20657229
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of ductal carcinoma in situ in magnetic resonance imaging.
Facius M; Renz DM; Neubauer H; Böttcher J; Gajda M; Camara O; Kaiser WA
Clin Imaging; 2007; 31(6):394-400. PubMed ID: 17996602
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced MRI of ductal carcinoma in situ: characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings.
Mariano MN; van den Bosch MA; Daniel BL; Nowels KW; Birdwell RL; Fong KJ; Desmond PS; Plevritis S; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
J Magn Reson Imaging; 2005 Oct; 22(4):520-6. PubMed ID: 16142701
[TBL] [Abstract][Full Text] [Related]
8. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
[TBL] [Abstract][Full Text] [Related]
9. Clinical MR-mammography: are computer-assisted methods superior to visual or manual measurements for curve type analysis? A systematic approach.
Baltzer PA; Freiberg C; Beger S; Vag T; Dietzel M; Herzog AB; Gajda M; Camara O; Kaiser WA
Acad Radiol; 2009 Sep; 16(9):1070-6. PubMed ID: 19523854
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
Nishiura M; Yasuhiro T; Murase K
Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
12. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of ductal carcinoma in situ.
Orel SG; Mendonca MH; Reynolds C; Schnall MD; Solin LJ; Sullivan DC
Radiology; 1997 Feb; 202(2):413-20. PubMed ID: 9015067
[TBL] [Abstract][Full Text] [Related]
14. Potential of MR mammography to predict tumor grading of invasive breast cancer.
Dietzel M; Baltzer PA; Vag T; Zoubi R; Gröschel T; Burmeister H; Gajda M; Runnebaum IB; Kaiser WA
Rofo; 2011 Sep; 183(9):826-33. PubMed ID: 21442559
[TBL] [Abstract][Full Text] [Related]
15. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma.
Schouten van der Velden AP; Boetes C; Bult P; Wobbes T
Am J Surg; 2006 Aug; 192(2):172-8. PubMed ID: 16860625
[TBL] [Abstract][Full Text] [Related]
16. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation.
Tendulkar RD; Chellman-Jeffers M; Rybicki LA; Rim A; Kotwal A; Macklis R; Obi BB
Cancer; 2009 Apr; 115(8):1621-30. PubMed ID: 19224552
[TBL] [Abstract][Full Text] [Related]
17. Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features.
Shin HJ; Kim HH; Kim SM; Kwon GY; Gong G; Cho OK
AJR Am J Roentgenol; 2008 Feb; 190(2):516-25. PubMed ID: 18212241
[TBL] [Abstract][Full Text] [Related]
18. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.
Neubauer H; Li M; Kuehne-Heid R; Schneider A; Kaiser WA
Br J Radiol; 2003 Jan; 76(901):3-12. PubMed ID: 12595319
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between ductal carcinoma in situ and mastopathy using dynamic contrast-enhanced magnetic resonance imaging and a model of contrast enhancement.
Nishiura M; Tamaki Y; Murase K
Eur J Radiol; 2011 Dec; 80(3):740-3. PubMed ID: 21030170
[TBL] [Abstract][Full Text] [Related]
20. Signal intensity of normal breast tissue at MR mammography on midfield: applying a random coefficient model evaluating the effect of doubling the contrast dose.
Marklund M; Christensen R; Torp-Pedersen S; Thomsen C; Nolsøe CP
Eur J Radiol; 2009 Jan; 69(1):93-101. PubMed ID: 17961948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]